Who Owns Benitec Biopharma Stock?
NASDAQ: BNTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 96.19%
- Held by insiders
- 0.55%
- Institutional holders
- 123
- Institutions 96.2%
- Insiders 0.5%
- Public and other 3.3%
Who owns Benitec Biopharma stock?
Institutional investors own about 96.2% of Benitec Biopharma's shares, spread across 123 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.55% of BNTC.
The largest institutional holders are Montanova Capital LLC (33.10%), Jupiter Topco LLC (7.10%) and Franklin Templeton, Inc. (6.91%). Together, the top 10 institutions control 75.9% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their BNTC positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BNTC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Montanova Capital LLC | 11.55M | 33.10% | 0.0% |
| Jupiter Topco LLC | 2.48M | 7.10% | +100.0% |
| Franklin Templeton, Inc. | 2.41M | 6.91% | -0.0% |
| Adage Capital Partners GP L.L.C. | 2.12M | 6.08% | 0.0% |
| RA Capital Management, L.P. | 1.85M | 5.30% | 0.0% |
| Nantahala Capital Management, LLC | 1.68M | 4.81% | +12.7% |
| Blackrock Inc. | 1.43M | 4.09% | +1.5% |
| Vanguard Capital Management LLC | 1.04M | 2.97% | +8.5% |
| Simplify Asset Management, Inc. | 1.00M | 2.87% | -0.3% |
| Infinitum Asset Management, LLC | 923.01K | 2.65% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BNTC
| Fund | Shares | % Held |
|---|---|---|
| Simplify Exchange Traded Funds-Simplify Health Care ETF | 1.01M | 2.88% |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 995.15K | 2.85% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 649.54K | 1.86% |
| iShares Trust-iShares Russell 2000 ETF | 536.22K | 1.54% |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 357.53K | 1.02% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 281.90K | 0.81% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 234.66K | 0.67% |
| iShares Trust-iShares Russell 2000 Value ETF | 189.19K | 0.54% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 150.34K | 0.43% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 122.04K | 0.35% |
Frequently asked questions
Who is the largest shareholder of Benitec Biopharma?
Montanova Capital LLC is the largest institutional shareholder of BNTC, owning 33.10% of shares outstanding (11.55M shares) as of its latest 13F filing.
What percentage of Benitec Biopharma is owned by institutions?
Institutions own about 96.2% of BNTC shares and 96.7% of the public float.
How much of Benitec Biopharma do insiders own?
Insiders, such as officers and directors, own about 0.55% of BNTC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.